Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19] (Thrombosis Research (2020) 185 (13–19), (S0049384819304931), (10.1016/j.thromres.2019.11.007))

F. I. Mulder; N. van Es; N. Kraaijpoel; M. Di Nisio; M. Carrier; A. Duggal; M. Gaddh; D. Garcia; M. A. Grosso; A. K. Kakkar; M. F. Mercuri; S. Middeldorp; G. Royle; A. Segers; S. Shivakumar; P. Verhamme; T. Wang; J. I. Weitz; G. Zhang; H. R. Büller; G. Raskob

doi:10.1016/j.thromres.2020.02.022

Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19] (Thrombosis Research (2020) 185 (13–19), (S0049384819304931), (10.1016/j.thromres.2019.11.007))

F. I. Mulder, N. van Es, N. Kraaijpoel, M. Di Nisio, M. Carrier, A. Duggal, M. Gaddh, D. Garcia, M. A. Grosso, A. K. Kakkar, M. F. Mercuri, S. Middeldorp, G. Royle, A. Segers, S. Shivakumar, P. Verhamme, T. Wang, J. I. Weitz, G. Zhang, H. R. BüllerG. Raskob

Résultat de recherche: Comment/debate › examen par les pairs

2 Citations (Scopus)

Résumé

The authors regret that panel E of Fig. 1 was missing, showing the cumulative incidence of the primary outcome in hematologic cancer. The authors would like to apologise for any inconvenience caused.

Langue d'origine	English
Pages (de-à)	156-159
Nombre de pages	4
Journal	Thrombosis Research
Volume	191
DOI	https://doi.org/10.1016/j.thromres.2020.02.022
Statut de publication	Published - juill. 2020
Publié à l'externe	Oui

Note bibliographique

Publisher Copyright:
© 2020

ASJC Scopus Subject Areas

Hematology

PubMed: MeSH publication types

Journal Article
Published Erratum

ODD de l’ONU

Cette action contribue à la réalisation des objectifs de développement durable suivants

Accès au document

10.1016/j.thromres.2020.02.022

Autres fichiers et liens

Empreinte numérique

Plonger dans les sujets de recherche 'Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19] (Thrombosis Research (2020) 185 (13–19), (S0049384819304931), (10.1016/j.thromres.2019.11.007))'. Ensemble, ils forment une empreinte numérique unique.

Citer

Mulder, F. I., van Es, N., Kraaijpoel, N., Di Nisio, M., Carrier, M., Duggal, A., Gaddh, M., Garcia, D., Grosso, M. A., Kakkar, A. K., Mercuri, M. F., Middeldorp, S., Royle, G., Segers, A., Shivakumar, S., Verhamme, P., Wang, T., Weitz, J. I., Zhang, G., ... Raskob, G. (2020). Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19] (Thrombosis Research (2020) 185 (13–19), (S0049384819304931), (10.1016/j.thromres.2019.11.007)). Thrombosis Research, 191, 156-159. https://doi.org/10.1016/j.thromres.2020.02.022

Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19] (Thrombosis Research (2020) 185 (13–19), (S0049384819304931), (10.1016/j.thromres.2019.11.007)). / Mulder, F. I.; van Es, N.; Kraaijpoel, N. et al.
Dans: Thrombosis Research, Vol. 191, 07.2020, p. 156-159.

Résultat de recherche: Comment/debate › examen par les pairs

Mulder, FI, van Es, N, Kraaijpoel, N, Di Nisio, M, Carrier, M, Duggal, A, Gaddh, M, Garcia, D, Grosso, MA, Kakkar, AK, Mercuri, MF, Middeldorp, S, Royle, G, Segers, A, Shivakumar, S, Verhamme, P, Wang, T, Weitz, JI, Zhang, G, Büller, HR & Raskob, G 2020, 'Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19] (Thrombosis Research (2020) 185 (13–19), (S0049384819304931), (10.1016/j.thromres.2019.11.007))', Thrombosis Research, vol. 191, pp. 156-159. https://doi.org/10.1016/j.thromres.2020.02.022

Mulder FI, van Es N, Kraaijpoel N, Di Nisio M, Carrier M, Duggal A et al. Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19] (Thrombosis Research (2020) 185 (13–19), (S0049384819304931), (10.1016/j.thromres.2019.11.007)). Thrombosis Research. 2020 juill.;191:156-159. doi: 10.1016/j.thromres.2020.02.022

Mulder, F. I. ; van Es, N. ; Kraaijpoel, N. et al. / Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer : Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19] (Thrombosis Research (2020) 185 (13–19), (S0049384819304931), (10.1016/j.thromres.2019.11.007)). Dans: Thrombosis Research. 2020 ; Vol. 191. pp. 156-159.

@article{708b1c84f7d245678ada0bb4ae270c69,

title = "Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19] (Thrombosis Research (2020) 185 (13–19), (S0049384819304931), (10.1016/j.thromres.2019.11.007))",

abstract = "The authors regret that panel E of Fig. 1 was missing, showing the cumulative incidence of the primary outcome in hematologic cancer. The authors would like to apologise for any inconvenience caused.",

author = "Mulder, {F. I.} and {van Es}, N. and N. Kraaijpoel and {Di Nisio}, M. and M. Carrier and A. Duggal and M. Gaddh and D. Garcia and Grosso, {M. A.} and Kakkar, {A. K.} and Mercuri, {M. F.} and S. Middeldorp and G. Royle and A. Segers and S. Shivakumar and P. Verhamme and T. Wang and Weitz, {J. I.} and G. Zhang and B{\"u}ller, {H. R.} and G. Raskob",

note = "Publisher Copyright: {\textcopyright} 2020",

year = "2020",

month = jul,

doi = "10.1016/j.thromres.2020.02.022",

language = "English",

volume = "191",

pages = "156--159",

journal = "Thrombosis Research",

issn = "0049-3848",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer

T2 - Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19] (Thrombosis Research (2020) 185 (13–19), (S0049384819304931), (10.1016/j.thromres.2019.11.007))

AU - Mulder, F. I.

AU - van Es, N.

AU - Kraaijpoel, N.

AU - Di Nisio, M.

AU - Carrier, M.

AU - Duggal, A.

AU - Gaddh, M.

AU - Garcia, D.

AU - Grosso, M. A.

AU - Kakkar, A. K.

AU - Mercuri, M. F.

AU - Middeldorp, S.

AU - Royle, G.

AU - Segers, A.

AU - Shivakumar, S.

AU - Verhamme, P.

AU - Wang, T.

AU - Weitz, J. I.

AU - Zhang, G.

AU - Büller, H. R.

AU - Raskob, G.

PY - 2020/7

Y1 - 2020/7

N2 - The authors regret that panel E of Fig. 1 was missing, showing the cumulative incidence of the primary outcome in hematologic cancer. The authors would like to apologise for any inconvenience caused.

AB - The authors regret that panel E of Fig. 1 was missing, showing the cumulative incidence of the primary outcome in hematologic cancer. The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85081225167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081225167&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2020.02.022

DO - 10.1016/j.thromres.2020.02.022

M3 - Comment/debate

C2 - 32151398

AN - SCOPUS:85081225167

SN - 0049-3848

VL - 191

SP - 156

EP - 159

JO - Thrombosis Research

JF - Thrombosis Research

ER -